サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1233638

前臨床CROの世界市場：命を救う新薬の開発ニーズの高まりが前臨床試験への投資を後押し

Market Study on Preclinical CRO: The rising need for the development of new life-saving drugs is boosting investments in preclinical studies
出版日: | 発行: Persistence Market Research | ページ情報: 英文 250 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
前臨床CROの世界市場：命を救う新薬の開発ニーズの高まりが前臨床試験への投資を後押し
出版日: 2023年01月31日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の前臨床CRO市場について調査分析し、市場概要、市場動向、市場分析、競合分析など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類法
  • 市場の定義/範囲/制限

第3章 市場リスクと動向の評価

  • リスクアセスメント
  • 市場に影響を与える主要な動向
  • 処方と製品開発の動向

第4章 市場の背景と基礎データポイント

  • 世界の前臨床CRO市場（10億米ドル）
  • 前臨床CRO市場の機会評価（10億米ドル）
    • 利用可能な市場の合計
    • サービス可能で利用可能な市場
    • サービス可能で獲得可能な市場
  • 市場シナリオ予測
    • 楽観的シナリオでの需要
    • 可能性のあるシナリオでの需要
    • 保守的シナリオでの需要
  • 投資の実現可能性分析
    • 確立された市場への投資
    • 新興市場への投資
  • 予測要因－関連性と影響
    • 主要企業の成長実績
    • 世界の前臨床CRO市場の成長
    • 前臨床CROの採用率：国別
  • 市場力学
    • 市場の促進要因と影響評価
    • 顕著な市場課題と影響評価
    • 前臨床CROの市場機会
    • 世界市場の顕著な動向とその影響評価

第5章 主な成功要因

  • メーカーによる普及率の低い高成長市場への注力
  • 高い機会を生み出す銀行セグメント
  • ピアベンチマーク

第6章 世界の前臨床CRO市場の需要分析と予測

  • 過去の市場分析
  • 現在および将来の市場予測
  • 前年比成長動向分析

第7章 世界の前臨床CRO市場価値分析と予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長動向分析

第8章 世界の前臨床CRO市場分析と予測：サービスタイプ別

  • イントロダクション/主な調査結果
  • 過去の市場分析：サービスタイプ別
  • 現在および将来の市場分析と予測：サービスタイプ別
    • 生物分析およびDMPK研究
    • 毒性試験
    • 化合物管理
    • 化学
    • 安全性薬理学
    • その他
  • 市場魅力度分析：サービスタイプ別

第9章 世界の前臨床CRO市場分析と予測：最終用途別

  • イントロダクション/主な調査結果
  • 過去の市場分析：最終用途別
  • 現在および将来の市場分析と予測：最終用途別
    • バイオ医薬品企業
    • 政府および学術機関
    • 医療機器企業
  • 市場の魅力分析：最終用途別

第10章 世界の前臨床CRO市場分析と予測：地域別

  • イントロダクション
  • 過去の市場分析：地域別
  • 現在の市場と分析と予測：地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • アジア太平洋
    • 中東およびアフリカ
  • 市場魅力度分析：地域別

第11章 北米の前臨床CRO市場の分析と予測

第12章 ラテンアメリカの前臨床CRO市場分析と予測

第13章 欧州の前臨床CRO市場の分析と予測

第14章 アジア太平洋の前臨床CRO市場の分析と予測

第15章 中東およびアフリカの前臨床CRO市場分析と予測

第16章 主要国の前臨床CRO市場分析と予測

  • イントロダクション
    • 市場価値比率分析：主要国別
    • 世界と国の成長比較
  • 米国の前臨床CRO市場分析
  • カナダの前臨床CRO市場分析
  • メキシコの前臨床CRO市場分析
  • ブラジルの前臨床CRO市場分析
  • ドイツの前臨床CRO市場分析
  • フランスの前臨床CRO市場分析
  • イタリアの前臨床CRO市場分析
  • スペインの前臨床CRO市場分析
  • 英国の前臨床CRO市場分析
  • オランダの前臨床CRO市場分析
  • 中国の前臨床CRO市場分析
  • 日本の前臨床CRO市場分析
  • 韓国の前臨床CRO市場分析
  • サウジアラビアの前臨床CRO市場分析
  • 南アフリカの前臨床CRO市場分析
  • アラブ首長国連邦の前臨床CRO市場分析

第17章 市場構造分析

  • 市場分析：企業層別
  • 市場集中
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析
    • 地域フットプリント：企業別
    • 製品フットプリント：企業別

第18章 競合分析

  • 競合ダッシュボード
  • 競合のベンチマーク
  • 競合の詳細
    • Eurofins Scientific
    • PRA Health Sciences
    • Medpace
    • Pharmaceutical Product Development
    • Icon Plc
    • Wuxi Apptec
    • MPI Research

第19章 使用される仮定と頭字語

第20章 調査手法

図表

List of Tables

  • Table 1: Global Preclinical CRO Market Value (US$ Bn), By Service Type, 2018 - 2022
  • Table 2: Global Preclinical CRO Market Value (US$ Bn), By Service Type, 2023 - 2033
  • Table 3: Global Preclinical CRO Market Value (US$ Bn), By End-use, 2018 - 2022
  • Table 4: Global Preclinical CRO Market Value (US$ Bn), By End-use, 2023 - 2033
  • Table 5: Global Preclinical CRO Market, By Region, 2018 - 2022
  • Table 6: Global Preclinical CRO Market, By Region, 2023 - 2033
  • Table 7: North America Preclinical CRO Market Value (US$ Bn), By Service Type, 2018 - 2022
  • Table 8: North America Preclinical CRO Market Value (US$ Bn), By Service Type, 2023 - 2033
  • Table 9: North America Preclinical CRO Market Value (US$ Bn), By End-use, 2018 - 2022
  • Table 10: North America Preclinical CRO Market Value (US$ Bn), By End-use, 2023 - 2033
  • Table 11: North America Preclinical CRO Market, By Country, 2018 - 2022
  • Table 12: North America Preclinical CRO Market, By Country, 2023 - 2033
  • Table 13: Latin America Preclinical CRO Market Value (US$ Bn), By Service Type, 2018 - 2022
  • Table 14: Latin America Preclinical CRO Market Value (US$ Bn), By Service Type, 2023 - 2033
  • Table 15: Latin America Preclinical CRO Market Value (US$ Bn), By End-use, 2018 - 2022
  • Table 16: Latin America Preclinical CRO Market Value (US$ Bn), By End-use, 2023 - 2033
  • Table 17: Latin America Preclinical CRO Market, By Country, 2018 - 2022
  • Table 18: Latin America Preclinical CRO Market, By Country, 2023 - 2033
  • Table 19: Europe Preclinical CRO Market Value (US$ Bn), By Service Type, 2018 - 2022
  • Table 20: Europe Preclinical CRO Market Value (US$ Bn), By Service Type, 2023 - 2033
  • Table 21: Europe Preclinical CRO Market Value (US$ Bn), By End-use, 2018 - 2022
  • Table 22: Europe Preclinical CRO Market Value (US$ Bn), By End-use, 2023 - 2033
  • Table 23: Europe Preclinical CRO Market, By Country, 2018 - 2022
  • Table 24: Europe Preclinical CRO Market, By Country, 2023 - 2033
  • Table 25: APAC Preclinical CRO Market Value (US$ Bn), By Service Type, 2018 - 2022
  • Table 26: APAC Preclinical CRO Market Value (US$ Bn), By Service Type, 2023 - 2033
  • Table 27: APAC Preclinical CRO Market Value (US$ Bn), By End-use, 2018 - 2022
  • Table 28: APAC Preclinical CRO Market Value (US$ Bn), By End-use, 2023 - 2033
  • Table 29: APAC Preclinical CRO Market, By Country, 2018 - 2022
  • Table 30: APAC Preclinical CRO Market, By Country, 2023 - 2033
  • Table 31: MEA Preclinical CRO Market Value (US$ Bn), By Service Type, 2018 - 2022
  • Table 32: MEA Preclinical CRO Market Value (US$ Bn), By Service Type, 2023 - 2033
  • Table 33: MEA Preclinical CRO Market Value (US$ Bn), By End-use, 2018 - 2022
  • Table 34: MEA Preclinical CRO Market Value (US$ Bn), By End-use, 2023 - 2033
  • Table 35: MEA Preclinical CRO Market, By Country, 2018 - 2022
  • Table 36: MEA Preclinical CRO Market, By Country, 2023 - 2033
  • Table 37: Global Preclinical CRO Market Incremental $ Opportunity, By Service Type, 2018 - 2022
  • Table 38: Global Preclinical CRO Market Incremental $ Opportunity, By End-use, 2023 - 2033
  • Table 39: Global Preclinical CRO Market Incremental $ Opportunity, By Region, 2023 - 2033
  • Table 40: North America Preclinical CRO Market Incremental $ Opportunity, By Service Type, 2018 - 2022
  • Table 41: North America Preclinical CRO Market Incremental $ Opportunity, By End-use, 2023 - 2033
  • Table 42: North America Preclinical CRO Market Incremental $ Opportunity, By Country, 2023 - 2033
  • Table 43: Latin America Preclinical CRO Market Incremental $ Opportunity, By Service Type, 2018 - 2022
  • Table 44: Latin America Preclinical CRO Market Incremental $ Opportunity, By End-use, 2023 - 2033
  • Table 45: Latin America Preclinical CRO Market Incremental $ Opportunity, By Country, 2023 - 2033
  • Table 46: Europe Preclinical CRO Market Incremental $ Opportunity, By Service Type, 2018 - 2022
  • Table 47: Europe Preclinical CRO Market Incremental $ Opportunity, By End-use, 2023 - 2033
  • Table 48: Europe Preclinical CRO Market Incremental $ Opportunity, By Country, 2023 - 2033
  • Table 49: APAC Preclinical CRO Market Incremental $ Opportunity, By Service Type, 2018 - 2022
  • Table 50: APAC Preclinical CRO Market Incremental $ Opportunity, By End-use, 2023 - 2033
  • Table 51: APAC Preclinical CRO Market Incremental $ Opportunity, By Country, 2023 - 2033
  • Table 52: MEA Preclinical CRO Market Incremental $ Opportunity, By Service Type, 2018 - 2022
  • Table 53: MEA Preclinical CRO Market Incremental $ Opportunity, By End-use, 2023 - 2033
  • Table 54: MEA Preclinical CRO Market Incremental $ Opportunity, By Country, 2023 - 2033

List of Figures

  • Figure 1: Global Preclinical CRO Market Value (US$ Bn) and Year-on-Year Growth, 2018-2033
  • Figure 2: Global Preclinical CRO Market Absolute $ Historical Gain (2018 - 2022) and Opportunity (2023 - 2033), US$ Bn
  • Figure 3: Global Preclinical CRO Market Share, By Service Type, 2023 & 2033
  • Figure 4: Global Preclinical CRO Market Y-o-Y Growth Projections, By Service Type - 2023-2033
  • Figure 5: Global Preclinical CRO Market Attractiveness Index, By Service Type - 2023-2033
  • Figure 6: Global Preclinical CRO Market Share, By End-use, 2023 & 2033
  • Figure 7: Global Preclinical CRO Market Y-o-Y Growth Projections, By End-use - 2023-2033
  • Figure 8: Global Preclinical CRO Market Attractiveness Index, By End-use - 2023-2033
  • Figure 9: Global Preclinical CRO Market Share, By Region, 2023 & 2033
  • Figure 10: Global Preclinical CRO Market Y-o-Y Growth Projections, By Region - 2023-2033
  • Figure 11: Global Preclinical CRO Market Attractiveness Index, By Region - 2023-2033
  • Figure 12: North America Preclinical CRO Market Value (US$ Bn) and Year-on-Year Growth, 2018-2033
  • Figure 13: North America Preclinical CRO Market Absolute $ Opportunity Historical (2018 - 2022) and Forecast Period (2023 - 2033), US$ Bn
  • Figure 14: North America Preclinical CRO Market Share, By Service Type, 2023 & 2033
  • Figure 15: North America Preclinical CRO Market Y-o-Y Growth Projections, By Service Type - 2023-2033
  • Figure 16: North America Preclinical CRO Market Attractiveness Index, By Service Type - 2023-2033
  • Figure 17: North America Preclinical CRO Market Share, By End-use, 2023 & 2033
  • Figure 18: North America Preclinical CRO Market Y-o-Y Growth Projections, By End-use - 2023-2033
  • Figure 19: North America Preclinical CRO Market Attractiveness Index, By End-use - 2023-2033
  • Figure 20: North America Preclinical CRO Market Share, By Country, 2023 & 2033
  • Figure 21: North America Market Y-o-Y Growth Projections, By Country - 2023-2033
  • Figure 22: North America Market Attractiveness Index, By Country - 2023-2033
  • Figure 23: Latin America Preclinical CRO Market Value (US$ Bn) and Year-on-Year Growth, 2018-2033
  • Figure 24: Latin America Preclinical CRO Market Absolute $ Opportunity Historical (2018 - 2022) and Forecast Period (2023 - 2033), US$ Bn
  • Figure 25: Latin America Preclinical CRO Market Share, By Service Type, 2023 & 2033
  • Figure 26: Latin America Preclinical CRO Market Y-o-Y Growth Projections, By Service Type - 2023-2033
  • Figure 27: Latin America Preclinical CRO Market Attractiveness Index, By Service Type - 2023-2033
  • Figure 28: Latin America Preclinical CRO Market Share, By End-use, 2023 & 2033
  • Figure 29: Latin America Preclinical CRO Market Y-o-Y Growth Projections, By End-use - 2023-2033
  • Figure 30: Latin America Preclinical CRO Market Attractiveness Index, By End-use - 2023-2033
  • Figure 31: Latin America Preclinical CRO Market Share, By Country, 2023 & 2033
  • Figure 32: Latin America Preclinical CRO Market Y-o-Y Growth Projections, By Country - 2023-2033
  • Figure 33: Latin America Preclinical CRO Market Attractiveness Index, By Country - 2023-2033
  • Figure 34: Europe Preclinical CRO Market Value (US$ Bn) and Year-on-Year Growth, 2018-2033
  • Figure 35: Europe Preclinical CRO Market Absolute $ Opportunity Historical (2018 - 2022) and Forecast Period (2023 - 2033), US$ Bn
  • Figure 36: Europe Preclinical CRO Market Share, By Service Type, 2023 & 2033
  • Figure 37: Europe Preclinical CRO Market Y-o-Y Growth Projections, By Service Type - 2023-2033
  • Figure 38: Europe Preclinical CRO Market Attractiveness Index, By Service Type - 2023-2033
  • Figure 39: Europe Preclinical CRO Market Share, By End-use, 2023 & 2033
  • Figure 40: Europe Preclinical CRO Market Y-o-Y Growth Projections, By End-use - 2023-2033
  • Figure 41: Europe Preclinical CRO Market Attractiveness Index, By End-use - 2023-2033
  • Figure 42: Europe Preclinical CRO Market Share, By Country, 2023 & 2033
  • Figure 43: Europe Preclinical CRO Market Y-o-Y Growth Projections, By Country - 2023-2033
  • Figure 44: Europe Preclinical CRO Market Attractiveness Index, By Country - 2023-2033
  • Figure 45: MEA Preclinical CRO Market Value (US$ Bn) and Year-on-Year Growth, 2018-2033
  • Figure 46: MEA Preclinical CRO Market Absolute $ Opportunity Historical (2018 - 2022) and Forecast Period (2023 - 2033), US$ Bn
  • Figure 47: MEA Preclinical CRO Market Share, By Service Type, 2023 & 2033
  • Figure 48: MEA Preclinical CRO Market Y-o-Y Growth Projections, By Service Type - 2023-2033
  • Figure 49: MEA Preclinical CRO Market Attractiveness Index, By Service Type - 2023-2033
  • Figure 50: MEA Preclinical CRO Market Share, By End-use, 2023 & 2033
  • Figure 51: MEA Preclinical CRO Market Y-o-Y Growth Projections, By End-use - 2023-2033
  • Figure 52: MEA Preclinical CRO Market Attractiveness Index, By End-use - 2023-2033
  • Figure 53: MEA Preclinical CRO Market Share, By Country, 2023 & 2033
  • Figure 54: MEA Preclinical CRO Market Y-o-Y Growth Projections, By Country - 2023-2033
  • Figure 55: MEA Preclinical CRO Market Attractiveness Index, By Country - 2023-2033
  • Figure 56: APAC Preclinical CRO Market Value (US$ Bn) and Year-on-Year Growth, 2018-2033
  • Figure 57: APAC Preclinical CRO Market Absolute $ Opportunity Historical (2018 - 2022) and Forecast Period (2023 - 2033), US$ Bn
  • Figure 58: APAC Preclinical CRO Market Share, By Service Type, 2023 & 2033
  • Figure 59: APAC Preclinical CRO Market Y-o-Y Growth Projections, By Service Type - 2023-2033
  • Figure 60: APAC Preclinical CRO Market Attractiveness Index, By Service Type - 2023-2033
  • Figure 61: APAC Preclinical CRO Market Share, By End-use, 2023 & 2033
  • Figure 62: APAC Preclinical CRO Market Y-o-Y Growth Projections, By End-use - 2023-2033
  • Figure 63: APAC Preclinical CRO Market Attractiveness Index, By End-use - 2023-2033
  • Figure 64: APAC Preclinical CRO Market Share, By Country, 2023 & 2033
  • Figure 65: APAC Preclinical CRO Market Y-o-Y Growth Projections, By Country - 2023-2033
  • Figure 66: APAC Preclinical CRO Market Attractiveness Index, By Country - 2023-2033
  • Figure 67: US Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 68: US Preclinical CRO Market Share, By Service Type, 2022
  • Figure 69: US Preclinical CRO Market Share, By End-use, 2022
  • Figure 70: Canada Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 71: Canada Preclinical CRO Market Share, By Service Type, 2022
  • Figure 72: Canada Preclinical CRO Market Share, By End-use, 2022
  • Figure 73: Brazil Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 74: Brazil Preclinical CRO Market Share, By Service Type, 2022
  • Figure 75: Brazil Preclinical CRO Market Share, By End-use, 2022
  • Figure 76: Mexico Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 77: Mexico Preclinical CRO Market Share, By Service Type, 2022
  • Figure 78: Mexico Preclinical CRO Market Share, By End-use, 2022
  • Figure 79: Germany Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 80: Germany Preclinical CRO Market Share, By Service Type, 2022
  • Figure 81: Germany Preclinical CRO Market Share, By End-use, 2022
  • Figure 82: U.K. Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 83: U.K. Preclinical CRO Market Share, By Service Type, 2022
  • Figure 84: U.K. Preclinical CRO Market Share, By End-use, 2022
  • Figure 85: France Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 86: France Preclinical CRO Market Share, By Service Type, 2022
  • Figure 87: France Preclinical CRO Market Share, By End-use, 2022
  • Figure 88: Italy Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 89: Italy Preclinical CRO Market Share, By Service Type, 2022
  • Figure 90: Italy Preclinical CRO Market Share, By End-use, 2022
  • Figure 91: Spain Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 92: Spain Preclinical CRO Market Share, By Service Type, 2022
  • Figure 93: Spain Preclinical CRO Market Share, By End-use, 2022
  • Figure 94: Netherlands Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 95: Netherlands Preclinical CRO Market Share, By Service Type, 2022
  • Figure 96: Netherlands Preclinical CRO Market Share, By End-use, 2022
  • Figure 97: China Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 98: China Preclinical CRO Market Share, By Service Type, 2022
  • Figure 99: China Preclinical CRO Market Share, By End-use, 2022
  • Figure 100: Japan Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 101: Japan Preclinical CRO Market Share, By Service Type, 2022
  • Figure 102: Japan Preclinical CRO Market Share, By End-use, 2022
  • Figure 103: South Korea Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 104: South Korea Preclinical CRO Market Share, By Service Type, 2022
  • Figure 105: South Korea Preclinical CRO Market Share, By End-use, 2022
  • Figure 106: Saudi Arabia Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 107: Saudi Arabia Preclinical CRO Market Share, By Service Type, 2022
  • Figure 108: Saudi Arabia Preclinical CRO Market Share, By End-use, 2022
  • Figure 109: South Africa Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 110: South Africa Preclinical CRO Market Share, By Service Type, 2022
  • Figure 111: South Africa Preclinical CRO Market Share, By End-use, 2022
  • Figure 112: UAE Preclinical CRO Market Value (US$ Bn) and Forecast, 2023 - 2033
  • Figure 113: UAE Preclinical CRO Market Share, By Service Type, 2022
  • Figure 114: UAE Preclinical CRO Market Share, By End-use, 2022
目次
Product Code: PMRREP33295

Global Preclinical CRO Market: Global Industry Analysis 2018-2022 & Opportunity Assessment 2023-2033

A recent market study published by Persistence Market Research on the global Preclinical CRO market offers global industry analysis for 2018-2022 & opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

The global Preclinical CRO market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

By Service Type

Bioanalysis and DMPK studies

In vitro ADME

In-vivo PK

Toxicology Testing

GLP

Non-GLP

Compound Management

Process R&D

Custom Synthesis

Other Compound Managements

Chemistry

Medicinal Chemistry

Computation Chemistry

Safety Pharmacology

Other Service Types

By End-use

Biopharmaceutical Companies

Government and Academic Institutes

Medical Device Companies

On-premises

By Region

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

Report Chapters:

Chapter 01 - Executive Summary

  • The executive summary of the global Preclinical CRO market includes the global market analysis, proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the global Preclinical CRO market.

Chapter 02 - Market Overview

  • Readers can find the detailed segmentation and definition of the global Preclinical CRO market in this chapter, which will help them understand basic information about the global Preclinical CRO market. This section also highlights the inclusions and exclusions, which help the reader to understand the scope of the global Preclinical CRO market report.

Chapter 03 - Market Background

  • The associated industry assessment of the global Preclinical CRO market is carried out in this section. In addition, this chapter explains key macroeconomic factors that are expected to influence the growth of the global Preclinical CRO market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the market. It offers provides key market dynamics of the global Preclinical CRO market, which include drivers, restraints, and opportunities. Moreover, it will help readers understand key trends followed by leading manufacturers in the global Preclinical CRO market.

Chapter 04 - Global Preclinical CRO Market Analysis 2018-2022 and Forecast, 2023-2033

  • This section provides detailed analysis of the historical global Preclinical CRO market Value, along with an opportunity analysis of the future. Readers can also find the incremental opportunity for the current year (2022-2023) and an absolute opportunity for the forecast period (2023-2033).

Chapter 05 - Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, by Service Type

  • Based on components, the global Preclinical CRO market is segmented into (Software Tools: Bioanalysis and DMPK studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Other Service Types). In this chapter, readers can find market attractiveness analysis, based on service type.

Chapter 06 - Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, by End-use

  • Based on deployment mode, the global Preclinical CRO market is segmented into Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies. In this chapter, readers can find market attractiveness analysis, based on End-use.

Chapter 07 - Global Preclinical CRO Market Analysis 2018-2022 and Opportunity Assessment 2023-2033 by Region

  • This chapter explains how the global Preclinical CRO market will grow across various geographic regions, such as North America, Latin America, Europe, Asia Pacific and the Middle East and Africa (MEA).

Chapter 08 - North America Global Preclinical CRO Market market Analysis 2018-2022 & Forecast 2023-2033

  • This chapter includes a detailed analysis of the growth of the global Preclinical CRO market in the North America region, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, opportunities, and market growth based on components, End use, and countries in the North America region.

Chapter 09 - Latin America Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033

  • Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the global Preclinical CRO market in the Latin America region. This chapter also includes growth prospects of the global Preclinical CRO market in leading LATAM countries such as Brazil and Mexico.

Chapter 10 - Europe Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033

  • Important growth prospects of the global Preclinical CRO market based on its product type, price, and sales channel in several countries such as Germany, U.K., France, Italy, BENELUX, Nordics, Russia, and Rest of Europe are included in this chapter.

Chapter 11 - Asia Pacific Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033

  • This chapter includes a detailed analysis of the growth of the global Preclinical CRO market in the South Asia region, along with a country-wise assessment that includes, China, Japan and South Korea. Readers can also find regional trends, restraints, and market growth of countries in the Asia Pacific region.

Chapter 12 - Middle East and Africa Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033

  • This chapter offers insights into how the global Preclinical CRO market is expected to grow in major countries in the MEA region such as GCC Countries, South Africa, and the Turkey, during the forecast period 2023-2033.

Chapter 13 - Key Countries Preclinical CRO Market Analysis

  • This chapter offers insights into how the global Preclinical CRO market is expected to grow in key countries in the such as U.S., Canada, Brazil, Mexico, Germany, U.K., France, Italy, BENELUX, Nordic, Rest of Europe, China, Japan, South Korea, GCC, South Africa, and Turkey during the forecast period 2023-2033.

Chapter 14 - Market Structure Analysis

  • In this chapter, readers can find detailed information about tier analysis and market concentration of the key players in the global Preclinical CRO market along with their market presence analysis by region and product portfolio.

Chapter 15 - Competition Deep-Dive Analysis

  • In this chapter, readers can find a comprehensive list of manufacturers/ players in the global Preclinical CRO market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the key players in Preclinical CRO market includes Eurofins Scientific, PRA Health Sciences, Medpace, Pharmaceutical Product Development, ICON Plc, Wuxi Apptec, and MPI Research among others.

Chapter 16 - Assumptions and Acronyms

  • This chapter includes a list of acronyms and assumptions that provide a based to the information and statistics included in the global Preclinical CRO market report.

Chapter 17 - Research Methodology

  • This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on the global Preclinical CRO market.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Summary of Statistics
  • 1.3. Key Market Characteristics & Attributes
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

  • 3.1. Risk Assessment
  • 3.2. Key Trends Impacting the Market
  • 3.3. Formulation and Product Development Trends

4. Market Background and Foundation Data Points

  • 4.1. Global Preclinical CRO Market (US$ Bn)
  • 4.2. Preclinical CRO Market Opportunity Assessment (US$ Bn)
    • 4.2.1. Total Available Market
    • 4.2.2. Serviceable Addressable Market
    • 4.2.3. Serviceable Obtainable Market
  • 4.3. Market Scenario Forecast
    • 4.3.1. Demand in optimistic Scenario
    • 4.3.2. Demand in Likely Scenario
    • 4.3.3. Demand in Conservative Scenario
  • 4.4. Investment Feasibility Analysis
    • 4.4.1. Investment in Established Markets
      • 4.4.1.1. In Short Term
      • 4.4.1.2. In Long Term
    • 4.4.2. Investment in Emerging Markets
      • 4.4.2.1. In Short Term
      • 4.4.2.2. In Long Term
  • 4.5. Forecast Factors - Relevance & Impact
    • 4.5.1. Top Companies Historical Growth
    • 4.5.2. Global Preclinical CRO Market Growth
    • 4.5.3. Preclinical CRO Adoption Rate, By Country
  • 4.6. Market Dynamics
    • 4.6.1. Market Driving Factors and Impact Assessment
    • 4.6.2. Prominent Market Challenges and Impact Assessment
    • 4.6.3. Preclinical CRO Market Opportunities
    • 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

  • 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
  • 5.2. Banking on with Segments High Incremental Opportunity
  • 5.3. Peer Benchmarking

6. Global Preclinical CRO Market Demand Analysis 2018-2022 and Forecast, 2023-2033

  • 6.1. Historical Market Analysis, 2018-2022
  • 6.2. Current and Future Market Projections, 2023-2033
  • 6.3. Y-o-Y Growth Trend Analysis

7. Global Preclinical CRO Market Value Analysis 2018-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Bn) Analysis, 2018-2022
  • 7.2. Current and Future Market Value (US$ Bn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, By Service Service Type

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Service Type, 2018-2022
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Service Type, 2023-2033
    • 8.3.1. Bioanalysis and DMPK studies
      • 8.3.1.1. In vitro ADME
      • 8.3.1.2. In-vivo PK
    • 8.3.2. Toxicology Testing
      • 8.3.2.1. GLP
      • 8.3.2.2. Non-GLP
    • 8.3.3. Compund Management
      • 8.3.3.1. Process R&D
      • 8.3.3.2. Custom Synthesis
      • 8.3.3.3. Other Compound Management
    • 8.3.4. Chemistry
      • 8.3.4.1. Medicinal Chemistry
      • 8.3.4.2. Computation Chemistry
    • 8.3.5. Safety Pharmacology
    • 8.3.6. Other Service Types
  • 8.4. Market Attractiveness Analysis By Service Type

9. Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, By End-use

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By End-use, 2018-2022
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End-use, 2023-2033
    • 9.3.1. Biopharmaceutical Companies
    • 9.3.2. Government and Academic Institutes
    • 9.3.3. Medical Device Companies
  • 9.4. Market Attractiveness Analysis By End-use

10. Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, By Region

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Bn) Analysis By Region, 2018-2022
  • 10.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2023-2033
    • 10.3.1. North America
    • 10.3.2. Latin America
    • 10.3.3. Europe
    • 10.3.4. APAC
    • 10.3.5. Middle East and Africa (MEA)
  • 10.4. Market Attractiveness Analysis By Region

11. North America Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033

  • 11.1. Introduction
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 11.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
    • 11.4.1. By Country
      • 11.4.1.1. U.S.
      • 11.4.1.2. Canada
      • 11.4.1.3. Rest of North America
    • 11.4.2. By Service Type
    • 11.4.3. By End-use
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Country
    • 11.5.2. By Service Type
    • 11.5.3. By End-use

12. Latin America Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033

  • 12.1. Introduction
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 12.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
    • 12.4.1. By Country
      • 12.4.1.1. Brazil
      • 12.4.1.2. Mexico
      • 12.4.1.3. Rest of Latin America
    • 12.4.2. By Service Type
    • 12.4.3. By End-use
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Country
    • 12.5.2. By Service Type
    • 12.5.3. By End-use

13. Europe Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
    • 13.4.1. By Country
      • 13.4.1.1. Germany
      • 13.4.1.2. France
      • 13.4.1.3. U.K.
      • 13.4.1.4. Italy
      • 13.4.1.5. Spain
      • 13.4.1.6. Netherlands
      • 13.4.1.7. Rest of Europe
    • 13.4.2. By Service Type
    • 13.4.3. By End-use
  • 13.5. Market Attractiveness Analysis
    • 13.5.1. By Country
    • 13.5.2. By Service Type
    • 13.5.3. By End-use

14. APAC Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Pricing Analysis
  • 14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
    • 14.4.1. By Country
      • 14.4.1.1. China
      • 14.4.1.2. Japan
      • 14.4.1.3. South Korea
      • 14.4.1.4. Rest of APAC
    • 14.4.2. By Service Type
    • 14.4.3. By End-use
  • 14.5. Market Attractiveness Analysis
    • 14.5.1. By Country
    • 14.5.2. By Service Type
    • 14.5.3. By End-use

15. Middle East and Africa Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Pricing Analysis
  • 15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
  • 15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
    • 15.4.1. By Country
      • 15.4.1.1. Saudi Arabia
      • 15.4.1.2. South Africa
      • 15.4.1.3. UAE
      • 15.4.1.4. Rest of Middle East and Africa
    • 15.4.2. By Service Type
    • 15.4.3. By End-use
  • 15.5. Market Attractiveness Analysis
    • 15.5.1. By Country
    • 15.5.2. By Service Type
    • 15.5.3. By End-use

16. Key Countries Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033

  • 16.1. Introduction
    • 16.1.1. Market Value Proportion Analysis, By Key Countries
    • 16.1.2. Global Vs. Country Growth Comparison
  • 16.2. US Preclinical CRO Market Analysis
    • 16.2.1. Value Proportion Analysis by Market Taxonomy
    • 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.2.2.1. By Service Type
      • 16.2.2.2. By End-use
  • 16.3. Canada Preclinical CRO Market Analysis
    • 16.3.1. Value Proportion Analysis by Market Taxonomy
    • 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.3.2.1. By Service Type
      • 16.3.2.2. By End-use
  • 16.4. Mexico Preclinical CRO Market Analysis
    • 16.4.1. Value Proportion Analysis by Market Taxonomy
    • 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.4.2.1. By Service Type
      • 16.4.2.2. By End-use
  • 16.5. Brazil Preclinical CRO Market Analysis
    • 16.5.1. Value Proportion Analysis by Market Taxonomy
    • 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.5.2.1. By Service Type
      • 16.5.2.2. By End-use
  • 16.6. Germany Preclinical CRO Market Analysis
    • 16.6.1. Value Proportion Analysis by Market Taxonomy
    • 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.6.2.1. By Service Type
      • 16.6.2.2. By End-use
  • 16.7. France Preclinical CRO Market Analysis
    • 16.7.1. Value Proportion Analysis by Market Taxonomy
    • 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.7.2.1. By Service Type
      • 16.7.2.2. By End-use
  • 16.8. Italy Preclinical CRO Market Analysis
    • 16.8.1. Value Proportion Analysis by Market Taxonomy
    • 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.8.2.1. By Service Type
      • 16.8.2.2. By End-use
  • 16.9. Spain Preclinical CRO Market Analysis
    • 16.9.1. Value Proportion Analysis by Market Taxonomy
    • 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.9.2.1. By Service Type
      • 16.9.2.2. By End-use
  • 16.10. UK Preclinical CRO Market Analysis
    • 16.10.1. Value Proportion Analysis by Market Taxonomy
    • 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.10.2.1. By Service Type
      • 16.10.2.2. By End-use
  • 16.11. Netherlands Preclinical CRO Market Analysis
    • 16.11.1. Value Proportion Analysis by Market Taxonomy
    • 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.11.2.1. By Service Type
      • 16.11.2.2. By End-use
  • 16.12. China Preclinical CRO Market Analysis
    • 16.12.1. Value Proportion Analysis by Market Taxonomy
    • 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.12.2.1. By Service Type
      • 16.12.2.2. By End-use
  • 16.13. Japan Preclinical CRO Market Analysis
    • 16.13.1. Value Proportion Analysis by Market Taxonomy
    • 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.13.2.1. By Service Type
      • 16.13.2.2. By End-use
  • 16.14. South Korea Preclinical CRO Market Analysis
    • 16.14.1. Value Proportion Analysis by Market Taxonomy
    • 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.14.2.1. By Service Type
      • 16.14.2.2. By End-use
  • 16.15. Saudi Arabia Preclinical CRO Market Analysis
    • 16.15.1. Value Proportion Analysis by Market Taxonomy
    • 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.15.2.1. By Service Type
      • 16.15.2.2. By End-use
  • 16.16. South Africa Preclinical CRO Market Analysis
    • 16.16.1. Value Proportion Analysis by Market Taxonomy
    • 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.16.2.1. By Service Type
      • 16.16.2.2. By End-use
  • 16.17. UAE Preclinical CRO Market Analysis
    • 16.17.1. Value Proportion Analysis by Market Taxonomy
    • 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
      • 16.17.2.1. By Service Type
      • 16.17.2.2. By End-use
    • 16.17.3. Competition Landscape and Player Concentration in the Country

17. Market Structure Analysis

  • 17.1. Market Analysis by Tier of Companies
  • 17.2. Market Concentration
  • 17.3. Market Share Analysis of Top Players
  • 17.4. Market Presence Analysis
    • 17.4.1. By Regional footprint of Players
    • 17.4.2. Product footprint by Players

18. Competition Analysis

  • 18.1. Competition Dashboard
  • 18.2. Competition Benchmarking
  • 18.3. Competition Deep Dive
    • 18.3.1. Eurofins Scientific
      • 18.3.1.1. Overview
      • 18.3.1.2. Product Portfolio
      • 18.3.1.3. Sales Footprint
      • 18.3.1.4. Strategy Overview
    • 18.3.2. PRA Health Sciences
      • 18.3.2.1. Overview
      • 18.3.2.2. Product Portfolio
      • 18.3.2.3. Sales Footprint
      • 18.3.2.4. Strategy Overview
    • 18.3.3. Medpace
      • 18.3.3.1. Overview
      • 18.3.3.2. Product Portfolio
      • 18.3.3.3. Sales Footprint
      • 18.3.3.4. Strategy Overview
    • 18.3.4. Pharmaceutical Product Development
      • 18.3.4.1. Overview
      • 18.3.4.2. Product Portfolio
      • 18.3.4.3. Sales Footprint
      • 18.3.4.4. Strategy Overview
    • 18.3.5. Icon Plc
      • 18.3.5.1. Overview
      • 18.3.5.2. Product Portfolio
      • 18.3.5.3. Sales Footprint
      • 18.3.5.4. Strategy Overview
    • 18.3.6. Wuxi Apptec
      • 18.3.6.1. Overview
      • 18.3.6.2. Product Portfolio
      • 18.3.6.3. Sales Footprint
      • 18.3.6.4. Strategy Overview
    • 18.3.7. MPI Research
      • 18.3.7.1. Overview
      • 18.3.7.2. Product Portfolio
      • 18.3.7.3. Sales Footprint
      • 18.3.7.4. Strategy Overview

19. Assumptions and Acronyms Used

20. Research Methodology